Workflow
Worksport Announces Official Launch Date for SOLIS and COR Clean Energy Products
Globenewswire· 2025-10-30 12:31
Core Insights - Worksport Ltd. officially launches its SOLIS Solar Tonneau Cover and COR Portable Energy Storage System on November 28, 2025, marking a significant step into clean energy solutions [1][2] Product Launch and Pricing Details - The COR Starter Kit (Inverter + Battery) will be priced at $949, with the option to purchase additional batteries, while the SOLIS Solar Tonneau System will start at $1,999 [2] - The COR system can operate independently or in conjunction with the SOLIS solar array to create a portable, modular nano-grid for renewable energy [2] Revenue Potential and Strategic Impact - The initial rollout aims to deliver 1,000 COR units and 900 additional 1kWh battery packs, alongside a limited number of SOLIS solar tonneau covers, representing an initial revenue opportunity of approximately $2.45 million [4] - The company plans to scale production rapidly throughout 2026, targeting significant additional revenue [4] Market Expansion and Competitive Edge - The launch of SOLIS and COR broadens Worksport's customer demographics and market footprint, introducing a unique solar-powered ecosystem with no direct competition in the vehicle accessory market [6] - The tonneau cover business has shown explosive growth, increasing from $1.5 million in 2023 to an expected $24 million run rate by the end of 2025, with projections to exceed $100 million within two years [7] Product Validation and Performance - The COR portable power system has been validated through multiple performance tests, demonstrating its capability to power heavy industrial equipment in extreme conditions [8] - When paired with the SOLIS solar cover, the system forms a self-sustaining, portable nano-grid that can recharge faster than it discharges [8] Leadership Commentary - The CEO of Worksport emphasizes that the launch marks a new chapter for the company, integrating renewable power into the lifestyles of truck owners and clean-tech enthusiasts [9][10] Forward Outlook - The commercialization of SOLIS and COR is expected to accelerate Worksport's path to profitability and establish its position as a rising leader in the U.S. clean-tech sector [11] - Future plans include expanding the COR system into home and commercial applications, as well as adaptations for various industries [11]
Red River Bancshares, Inc. Reports Third Quarter 2025 Financial Results
Globenewswire· 2025-10-30 12:30
ALEXANDRIA, La., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Red River Bancshares, Inc. (the “Company”) (Nasdaq: RRBI), the holding company for Red River Bank (the “Bank”), announced today its unaudited financial results for the third quarter of 2025. Net income for the third quarter of 2025 was $10.8 million, or $1.63 per diluted common share (“EPS”), compared to $10.2 million, or $1.51 EPS, for the second quarter of 2025. For the third quarter of 2025, the quarterly return on assets was 1.34%, and the quarterly ret ...
Itron Announces Third Quarter 2025 Financial Results
Globenewswire· 2025-10-30 12:30
LIBERTY LAKE, Wash., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), which is innovating the way utilities and cities manage energy and water, announced today financial results for its third quarter ended September 30, 2025. Key results for the quarter include (compared with the third quarter of 2024): Revenue of $582 million, decreased 5%;GAAP net income attributable to Itron, Inc. of $66 million, decreased $12 million;GAAP diluted earnings per share of $1.41, decreased $0.29 per share;Non-GA ...
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
Globenewswire· 2025-10-30 12:30
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that it will report the Company’s third quarter 2025 financial results on Thursday, November 6, 2025, before the open of the U.S. financial markets. About Aligos Aligos Therapeutics, Inc. (NASDAQ: ALGS) is a clinical stage biopharmaceutical company fou ...
Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
Globenewswire· 2025-10-30 12:30
PDUFA Date Set for March 29, 2026BEDFORD, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that the U.S. Food and Drug Administration (FDA) has established a Prescription Drug User Fee Act (PDUFA) date for LNTH-2501 (Gallium-68 edotreotide). LNTH-2501 is a diagnostic kit for the preparation of Ga 68 ...
SEGG Media Charts a Bold Course into Web3 with $300M Digital Asset Initiative
Globenewswire· 2025-10-30 12:30
FORT WORTH, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- SEGG Media Corporation (Nasdaq: SEGG, LTRYW) (“SEGG Media” or “the Company”) today announced the launch of its Web3 and Digital Asset Strategy, a two-year roadmap to generate sustainable on-chain yield, accelerate tokenization across sports and entertainment, and embed blockchain infrastructure into its global media ecosystem. The initiative follows the creation of the SEGG Media Crypto Advisory Board, which is being established to provide guidance for go ...
Vivakor’s Trading Platform Launches Full-Scale Operations with $24 Million Commodity Transaction
Globenewswire· 2025-10-30 12:30
Dallas, TX, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Vivakor, Inc. (Nasdaq: VIVK) (“Vivakor” or the “Company”), an integrated provider of energy transportation, storage, reuse, and remediation services, today announced that its commodities trading platform, Vivakor Supply & Trading (“VST”), in cooperation with its financing wholesaler, initiated its first major commodity transaction. VST’s commodities operations are responsible for arranging transportation, logistics, and gathering operations for commodities purch ...
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
Globenewswire· 2025-10-30 12:30
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced plans to report its third quarter 2025 financial results and provide a business update on Friday, November 7th, 2025, before market open. The company will be hosting a teleconference in conjunction with this press release w ...
TechForce Robotics Accepted into NVIDIA Connect Program, Strengthening Position in AI-Driven Hospitality Automation
Globenewswire· 2025-10-30 12:30
Core Insights - Nightfood Holdings Inc., operating as TechForce Robotics, has been accepted into the NVIDIA Connect Program, marking a significant milestone in its development as an AI-driven company in the hospitality automation sector [1][2][6] - The collaboration with NVIDIA provides access to advanced tools and resources that will enhance TechForce Robotics' capabilities in robotics and AI, particularly in real-time training and decision-making [3][5] Company Overview - TechForce Robotics is focused on revolutionizing the hospitality industry by integrating AI-powered robotics with strategic hotel acquisitions, aiming to improve efficiency and reduce operating costs [7] - The company has an annualized revenue exceeding $10 million and a combined acquisition value of approximately $100 million, positioning itself for future growth and exchange readiness [6] Market Position - The global service robotics market is projected to exceed $170 billion by 2030, and TechForce Robotics is strategically positioned to capitalize on this growth through its dual focus on hotel ownership and Robotics-as-a-Service (RaaS) solutions [8]
Nexalin Technology Announces Regulatory Approval to Sell Gen 2 SYNC, 15 mA Neurostimulation DIFS™ Device in Israel
Globenewswire· 2025-10-30 12:30
HOUSTON, TX, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that its Gen-2 Console (“SYNC”), 15 milliamp (mA) neurostimulation device has been granted regulatory approval for sale in Israel by the Israeli Ministry of Health. Mark White, CEO of Nexalin Technology, stated, “We are extremely proud to have received regulatory clearance in Israel, which is recognized ...